Tempus is helping transform drug discovery by breaking down information silos to link together clinical, DNA, RNA, and whole slide pathology imaging data modalities. With this structured data, we can power AI and machine learning approaches to help accelerate drug development for patients.
to power large real-world evidence studies
with imaging data
Tempus is a leader in the field of personalized medicine, and like Genmab, Tempus has a mission to improve the lives of cancer patients. We are looking forward to expanding our exciting partnership with them and to the possibility of discovering important new oncology targets and biomarkers.
POWER YOUR INNOVATION AND DISCOVERY
Lens is a comprehensive, real-world, multi-modal data platform that enables Life Science companies to uncover new insights across the research and development spectrum. Top Pharma companies are using Lens to help them make smarter decisions, design more successful clinical trials, and bring molecules to market faster.
Lens empowers you to tackle your research and development needs:
Tempus View gives you near real time access to power your research initiatives. Interact with Tempus multi-modal data on-demand through an optimized cloud environment to help get the answers you need, when you need them.
Tempus Explore delivers speed, cost efficiency and deep domain expertise to help meet your research objectives. Derive insights from the full Tempus oncology database by leveraging Tempus bioinformatics experts.
Tempus Download offers a broad, typically multi-year relationship that supports numerous iterative research and development objectives that can span the lifecycle of your product. Get enterprise-wide access to Tempus multi-modal records by stakeholders across your organization in the indication(s) of your choice with this custom partnership model.
Inquire about collaboration opportunities with Tempus AI and Analytics Experts to support your drug development programs. We’ve established machine learning partnerships with numerous biopharmaceutical companies focused on areas such as: